|
EIF2AK1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.81910000396357E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.77289999997643E-06 |
| Normal-vs-Stage2 |
1.202240E-01 |
| Normal-vs-Stage3 |
5.633700E-02 |
| Normal-vs-Stage4 |
6.181600E-02 |
| Stage1-vs-Stage2 |
8.437200E-01 |
| Stage1-vs-Stage3 |
4.555200E-01 |
| Stage1-vs-Stage4 |
8.133800E-01 |
| Stage2-vs-Stage3 |
7.255600E-01 |
| Stage2-vs-Stage4 |
9.382000E-01 |
| Stage3-vs-Stage4 |
7.865000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.18040000055097E-07 |
| Normal-vs-AfricanAmerican |
1.281050E-03 |
| Normal-vs-Asian |
4.347000E-01 |
| Caucasian-vs-AfricanAmerican |
8.563800E-01 |
| Caucasian-vs-Asian |
7.680400E-01 |
| AfricanAmerican-vs-Asian |
8.182600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.80629999963134E-07 |
| Normal-vs-Female |
2.37849999999984E-05 |
| Male-vs-Female |
4.868200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.057600E-02 |
| Normal-vs-Extreme_Weight |
6.635500E-04 |
| Normal-vs-Obese |
2.48039999999339E-05 |
| Normal-vs-Extreme_Obese |
1.587840E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.092600E-01 |
| Normal_Weight-vs-Obese |
1.904240E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.508800E-01 |
| Extreme_Weight-vs-Obese |
6.681600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.661200E-01 |
| Obese-vs-Extreme_Obese |
6.503400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.431700E-04 |
| Normal-vs-Age(41-60Yrs) |
5.01360000182416E-08 |
| Normal-vs-Age(61-80Yrs) |
4.574500E-04 |
| Normal-vs-Age(81-100Yrs) |
5.244600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.078800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.375800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.063570E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.215700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.245200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.504600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.1823436914874E-13 |
| Normal-VS-Type2 PRCC |
9.791600E-01 |
| Normal-VS-KIRP CIMP |
4.798500E-03 |
| Normal-VS-Unclassified PRCC |
1.494420E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.31800000094884E-08 |
| Type1 PRCC-VS-KIRP CIMP |
5.519000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.500840E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.476600E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.121900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.199400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.247000E-01 |
| Normal-vs-N1 |
1.503550E-02 |
| Normal-vs-N2 |
2.775400E-03 |
| N0-vs-N1 |
4.562300E-02 |
| N0-vs-N2 |
1.866200E-01 |
| N1-vs-N2 |
8.234400E-01 |
|
|
